CY1108808T1 - Ενωσεις μοτιλιδης - Google Patents

Ενωσεις μοτιλιδης

Info

Publication number
CY1108808T1
CY1108808T1 CY20091100165T CY091100165T CY1108808T1 CY 1108808 T1 CY1108808 T1 CY 1108808T1 CY 20091100165 T CY20091100165 T CY 20091100165T CY 091100165 T CY091100165 T CY 091100165T CY 1108808 T1 CY1108808 T1 CY 1108808T1
Authority
CY
Cyprus
Prior art keywords
sup
motorcycle
units
diseases
formula
Prior art date
Application number
CY20091100165T
Other languages
English (en)
Inventor
Daniel Santi
Brian Metcalf
Christopher Carreras
Yaoquan Liu
Robert Mcdaniel
Eduardo J Rodriguez
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CY1108808T1 publication Critical patent/CY1108808T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Ενώσεις μοτιλίδης που έχουν τον τύπο (I), στον οποίο τα R1, R2, R3 και R4 είναι όπως ορίστηκαν στο παρόν, και μέθοδοι για την παρασκευή και χρήση στη θεραπεία νόσων ή παθήσεων οι οποίες χαρακτηρίζονται από εξασθενημένη γαστρική κινητικότητα.
CY20091100165T 2002-08-29 2009-02-13 Ενωσεις μοτιλιδης CY1108808T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40734502P 2002-08-29 2002-08-29
EP03755757A EP1532131B1 (en) 2002-08-29 2003-08-26 Motilide compounds

Publications (1)

Publication Number Publication Date
CY1108808T1 true CY1108808T1 (el) 2014-04-09

Family

ID=31978464

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100165T CY1108808T1 (el) 2002-08-29 2009-02-13 Ενωσεις μοτιλιδης

Country Status (15)

Country Link
US (1) US6946482B2 (el)
EP (1) EP1532131B1 (el)
JP (1) JP4796300B2 (el)
KR (1) KR101051613B1 (el)
CN (1) CN100363359C (el)
AT (1) ATE417856T1 (el)
AU (1) AU2003273254B2 (el)
CA (1) CA2492846C (el)
CY (1) CY1108808T1 (el)
DE (1) DE60325377D1 (el)
DK (1) DK1532131T3 (el)
ES (1) ES2316805T3 (el)
PT (1) PT1532131E (el)
SI (1) SI1532131T1 (el)
WO (1) WO2004019879A2 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063021B2 (en) 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
GB0327720D0 (en) * 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
UA87569C2 (ru) * 2005-05-24 2009-07-27 Пфайзер Инк. Соединения для лечения расстройств желудочно-кишечной моторики
NZ568763A (en) * 2005-12-08 2010-04-30 Pfizer Method for demethylating the 3'-dimethylamino group of erythromycin compounds
CA2662897C (en) 2006-09-11 2017-11-07 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
CN106138038B (zh) * 2015-04-28 2021-04-20 天津国际生物医药联合研究院 大环内酯类衍生物及其用途
CN106478541A (zh) * 2016-10-17 2017-03-08 南开大学 大环内酯类衍生物及其用途
CN106478542A (zh) * 2016-10-17 2017-03-08 南开大学 一种大环内脂类衍生物盐、其制备方法及用途

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US391594A (en) * 1888-10-23 Arc-extinguisher for electric switches or cut-outs
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4382086A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
PL136968B1 (en) 1983-02-10 1986-04-30 Tarchominskie Zaklad Farma Process for preparing cyclic 11,12-carbonate of erythromycin a
JPS60218321A (ja) * 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4857641A (en) * 1987-08-14 1989-08-15 Pfizer Inc. C.12 modified erythromycin A derivatives
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
US5190871A (en) * 1989-06-12 1993-03-02 Eli Lilly And Company Use of the site-specific integrating function of phage φC31
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US5523401A (en) * 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
DE69211845T2 (de) * 1991-04-09 1997-01-23 Abbott Lab Macrozyklische laktam-prokinetika
MX9300278A (es) * 1992-01-21 1993-12-31 Abbott Lab Compuestos de arilalcoxifenoxi-imidazolina.
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
US6066721A (en) * 1995-07-06 2000-05-23 Stanford University Method to produce novel polyketides
US5712146A (en) * 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
ATE286133T1 (de) * 1995-07-06 2005-01-15 Univ Leland Stanford Junior Zellfreie synthese von polyketiden
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
WO1997035590A1 (en) * 1996-03-25 1997-10-02 Platt Chris E 10-aza-9-deoxo-11-deoxy-erythromycin a and derivatives combined with sulfisoxazole
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5922849A (en) * 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1999021867A1 (fr) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6169168B1 (en) * 1997-10-29 2001-01-02 Taisho Pharmaceuticals Co., Ltd. Erythromycin A derivatives
US6084079A (en) * 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
WO2000024907A2 (en) * 1998-10-28 2000-05-04 Kosan Biosciences, Inc. Library of novel "unnatural" natural products
AU758421B2 (en) * 1998-10-29 2003-03-20 Kosan Biosciences, Inc. Recombinant oleandolide polyketide synthase
EP1144375A2 (en) 1999-01-27 2001-10-17 Kosan Biosciences Synthesis of oligoketides
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6524841B1 (en) 1999-10-08 2003-02-25 Kosan Biosciences, Inc. Recombinant megalomicin biosynthetic genes and uses thereof
US7011959B1 (en) 1999-10-27 2006-03-14 Kosan Biosciences, Inc. Heterologous production of polyketides
EP1255763A2 (en) * 2000-02-18 2002-11-13 Kosan Biosciences, Inc. Motilide compounds
US6838265B2 (en) * 2000-05-02 2005-01-04 Kosan Biosciences, Inc. Overproduction hosts for biosynthesis of polyketides
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
JP2004522726A (ja) * 2000-12-01 2004-07-29 コーサン バイオサイエンシーズ， インコーポレイテッド モチリド化合物
US6875576B2 (en) * 2001-02-15 2005-04-05 Kosan Biosciences, Inc. Method for evaluating therapeutic efficacy
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Also Published As

Publication number Publication date
US20040138150A1 (en) 2004-07-15
EP1532131A4 (en) 2007-05-30
AU2003273254A1 (en) 2004-03-19
KR20050038594A (ko) 2005-04-27
SI1532131T1 (sl) 2009-04-30
CN100363359C (zh) 2008-01-23
AU2003273254B2 (en) 2008-10-30
CN1665799A (zh) 2005-09-07
EP1532131A2 (en) 2005-05-25
ES2316805T3 (es) 2009-04-16
CA2492846A1 (en) 2004-03-11
US6946482B2 (en) 2005-09-20
CA2492846C (en) 2012-09-25
DK1532131T3 (da) 2009-02-09
PT1532131E (pt) 2009-02-18
KR101051613B1 (ko) 2011-07-25
WO2004019879A2 (en) 2004-03-11
JP2005537317A (ja) 2005-12-08
ATE417856T1 (de) 2009-01-15
WO2004019879A8 (en) 2004-07-29
DE60325377D1 (de) 2009-01-29
WO2004019879A3 (en) 2004-06-03
EP1532131B1 (en) 2008-12-17
JP4796300B2 (ja) 2011-10-19

Similar Documents

Publication Publication Date Title
CY1108808T1 (el) Ενωσεις μοτιλιδης
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
TW200630374A (en) Thiazolyldihydroindazoles
TW200509892A (en) Novel aminobenzophenone compounds
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
EA200802213A1 (ru) Способы лечения заболеваний крови
NO20055741D0 (no) Nye kjemiske forbindelser
ECSP055844A (es) Nuevos compuestos triciclicos
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
SE0302139D0 (sv) Novel compounds
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
IS5161A (is) Tetrahýdrópýridóefnasambönd
DE50310579D1 (de) Furancarboxamide
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
CY1105345T1 (el) Φαινυλαλκινια
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
NO20053562L (no) Nye aminobenzofenonforbindelser
GB0309440D0 (en) Quinolone derivatives